Morgan Stanley lowered the firm’s price target on Nike (NKE) to $74 from $80 and keeps an Equal Weight rating on the shares. While Q2 came in better than expected, forward guidance indicates that the fundamental trajectory is “set to get worse before it can get better,” while Nike’s path to inflection “remains uncertain,” the analyst tells investors. the firm thinks EPS risk lingers into FY26, “rendering it another reset year,” the analyst added.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NKE:
